Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mediwound Ltd - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MDWD
Nasdaq
2834
https://www.mediwound.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mediwound Ltd
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
- Mar 25th, 2024 1:55 pm
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'
- Mar 25th, 2024 12:50 pm
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
- Mar 24th, 2024 12:03 pm
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
- Mar 21st, 2024 12:25 pm
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
- Mar 21st, 2024 11:00 am
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
- Mar 14th, 2024 12:00 pm
Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well
- Mar 7th, 2024 11:30 am
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
- Mar 6th, 2024 1:46 pm
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
- Feb 12th, 2024 12:00 pm
MediWound to Participate in Two Upcoming Investor Conferences
- Feb 5th, 2024 1:00 pm
Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation
- Feb 1st, 2024 1:44 pm
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross
- Jan 15th, 2024 2:55 pm
Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet
- Jan 9th, 2024 11:21 pm
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions
- Jan 9th, 2024 1:48 pm
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
- Jan 9th, 2024 12:00 pm
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
- Dec 28th, 2023 12:00 pm
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
- Dec 21st, 2023 1:00 pm
MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
- Dec 18th, 2023 10:31 am
Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to Trade
- Dec 13th, 2023 2:55 pm
MediWound (NASDAQ:MDWD) investors are sitting on a loss of 75% if they invested five years ago
- Dec 5th, 2023 11:44 am
Scroll